• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ULTRAFLEX ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ULTRAFLEX ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL Back to Search Results
Model Number M00513750
Device Problems Activation, Positioning or Separation Problem (2906); Appropriate Term/Code Not Available (3191)
Patient Problems No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/04/2021
Event Type  malfunction  
Manufacturer Narrative
(b)(4).The device has not been received for analysis; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation on (b)(6) 2021 that an ultraflex esophageal ng distal release covered stent was to be implanted to treat a malignant stricture in the lower esophagus during an esophageal stent placement procedure performed on (b)(6) 2021.Reportedly, the patient's anatomy was not tortuous.According to the complainant, during the procedure, the deployment suture would not release.The stent was partially deployed on the delivery system when it was removed from the patient.Reportedly, the procedure was not completed because the same device was unavailable at the time of the procedure.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Manufacturer Narrative
Block h6: medical device problem code a27 is being used to capture the reportable issue of aborted/cancelled procedure.Block h10: an ultraflex esophageal ng distal release covered stent and delivery system were received for analysis.The stent was received partially deployed.Visual examination of the returned device found the shaft was kinked and the deployment suture was returned tangled up over the shaft.Microscopic inspection was performed and it was noted that the stent cover was damaged.Functional examination was performed, and the shaft bowed during deployment.The stent was found deformed; the outer diameter of the stent was measured and the middle section was found smaller than the specification.No other issues were noted to the stent and the delivery system.The reported event of stent partially deployed was confirmed.The damages noted to the returned device may likely be due to anatomical and procedural factors encountered during the procedure.The amount of force applied to the delivery system and the resistance felt during the procedure could have contributed to the kinks noted in the shaft, stent cover damage, and could have caused the tangled suture.Additionally, the stent being partially deployed could have caused the deformation of the stent after manual deployment.Therefore, a review and analysis of all available information indicated the most probable cause is adverse event related to procedure.A review of the manufacturing documentation for this device revealed that no anomalies or deviations related to the event occurred during manufacturing.
 
Event Description
It was reported to boston scientific corporation on january 04, 2021 that an ultraflex esophageal ng distal release covered stent was to be implanted to treat a malignant stricture in the lower esophagus during an esophageal stent placement procedure performed on (b)(6) 2021.Reportedly, the patient's anatomy was not tortuous.According to the complainant, during the procedure, the deployment suture would not release.The stent was partially deployed on the delivery system when it was removed from the patient.Reportedly, the procedure was not completed because the same device was unavailable at the time of the procedure.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAFLEX ESOPHAGEAL NG
Type of Device
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
MDR Report Key11214904
MDR Text Key228356604
Report Number3005099803-2021-00167
Device Sequence Number1
Product Code ESW
UDI-Device Identifier08714729649113
UDI-Public08714729649113
Combination Product (y/n)N
PMA/PMN Number
K091816
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 04/12/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/16/2022
Device Model NumberM00513750
Device Catalogue Number1375
Device Lot Number0025219672
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/24/2021
Initial Date Manufacturer Received 01/04/2021
Initial Date FDA Received01/22/2021
Supplement Dates Manufacturer Received03/17/2021
Supplement Dates FDA Received04/12/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-